glp-1 receptor agonist antipsychotic weight gain study Efficacy and Safety of Agonists for the Management of Antipsychotic-Induced Antipsychotic Weight Gain and Metabolic
Description
Semaglutide administered subcutaneously lowers HbA1c more than any other long-acting medication
These are trademarked names not affiliated with our platform
h - m , GLP-1MK-801 corrects body weight and fat mass relative to age-matched chow-fed control mice
Mol Metab 2019;30:72130
10.1056/NEJMoa1411892
